Sorry no Private privilages .The change is for orthopedic tissue ONLY 20% of business .Cry has lost the confidence of a large segment of the medical community not just on orthopedic tissue ,they have big class action and possible malpractise lawsuits pending as well . They have earnings next week I expect dismal at best . This news was somewhat a foregone conclusion ,it has traded into the mid $7.00 recently on the extension given by the FDA .If the market is at all efficent the run yesterday and today was short covering and a lot of short selling . BUT I"VE BEEN WRONG on buying this thing more times than I care to remember .
Market Data 
Markets 
AI
